Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  NOLAN KERMIT
 2. Date of Event Requiring Statement (Month/Day/Year)
02/07/2019		 3. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [SYNA]
(Last)
(First)
(Middle)
1251 MCKAY DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
See Remarks
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN JOSE, CA 95131		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 56,111 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   (2) 08/03/2019 Common Stock 5,109 (3) $ 25.5 D  
Employee Stock Option (Right to Buy)   (4) 08/02/2020 Common Stock 13,000 $ 31.73 D  
Employee Stock Option (Right to Buy)   (5) 10/31/2019 Common Stock 1,000 $ 23.16 D  
Employee Stock Option (Right to Buy)   (6) 01/28/2020 Common Stock 1,000 $ 35.76 D  
Employee Stock Option (Right to Buy)   (7) 04/29/2020 Common Stock 1,000 $ 42.57 D  
Employee Stock Option (Right to Buy)   (8) 08/05/2020 Common Stock 1,000 $ 39.8 D  
Employee Stock Option (Right to Buy)   (9) 10/28/2020 Common Stock 744 $ 46.5 D  
Employee Stock Option (Right to Buy)   (10) 01/27/2021 Common Stock 744 $ 60.22 D  
Employee Stock Option (Right to Buy)   (11) 04/28/2021 Common Stock 744 $ 61.4 D  
Employee Stock Option (Right to Buy)   (12) 08/01/2021 Common Stock 745 $ 78.11 D  
Employee Stock Option (Right to Buy)   (13) 10/24/2021 Common Stock 408 $ 62.105 D  
Employee Stock Option (Right to Buy)   (14) 01/30/2022 Common Stock 408 $ 76.81 D  
Employee Stock Option (Right to Buy)   (15) 04/24/2022 Common Stock 408 $ 85.69 D  
Employee Stock Option (Right to Buy)   (16) 07/31/2022 Common Stock 408 $ 79.38 D  
Employee Stock Option (Right to Buy)   (17) 10/23/2022 Common Stock 1,049 $ 89.29 D  
Employee Stock Option (Right to Buy)   (18) 01/23/2023 Common Stock 1,050 $ 73.31 D  
Employee Stock Option (Right to Buy)   (19) 04/29/2023 Common Stock 1,049 $ 71.55 D  
Employee Stock Option (Right to Buy)   (20) 07/23/2023 Common Stock 1,050 $ 51.95 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
NOLAN KERMIT
1251 MCKAY DRIVE
SAN JOSE, CA 95131		       See Remarks  

Signatures

Kermit Nolan 02/11/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes (i) 7,648 shares that were acquired upon delivery of vested deferred stock units, (ii) 17,531 shares underlying deferred stock units that are not yet vested and deliverable, and (iii) 1,354 shares released in connection with the vesting of performance-based market stock units granted on 12/13/17.
(2) 25% of the 18,000 shares subject to the option vested and became exercisable on the 12 month anniversary of the 7/27/09 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter until fully vested on 7/27/13.
(3) Does not include 12,891 shares underlying the option that were previously exercised.
(4) 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the 8/02/10 date of grant until fully vested on 8/02/14.
(5) 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 10/31/12 date of grant until fully vested on 10/29/15.
(6) 1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the 1/28/13 date of grant until fully vested on 1/28/16.
(7) 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 4/29/13 date of grant until fully vested on 4/29/16.
(8) 1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the 8/05/13 date of grant until fully vested on 8/05/16.
(9) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/28/13 date of grant until fully vested on 10/28/16.
(10) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/27/14 date of grant until fully vested on 1/27/17.
(11) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/28/14 date of grant until fully vested on 4/28/17.
(12) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 8/01/14 date of grant until fully vested on 8/01/17.
(13) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/24/14 date of grant until fully vested on 10/24/17.
(14) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/30/15 date of grant until fully vested on 1/30/18.
(15) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/24/15 date of grant until fully vested on 4/24/18.
(16) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 7/31/15 date of grant until fully vested on 7/31/18.
(17) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/23/15 date of grant until fully vested on 10/23/18.
(18) 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/29/16 date of grant until fully vested on 1/29/19.
(19) 1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 4/29/16 date of grant until fully vested on 4/29/19.
(20) 1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 7/29/16 date of grant until fully vested on 7/29/19.
 
Remarks:
The reporting person is the Corporate Vice President, Chief Accounting Officer, and Interim Chief Financial Officer.

Exhibit List

Exhibit 24 - Limited Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.